339 related articles for article (PubMed ID: 20451605)
1. Enhanced antitumor efficacy by paclitaxel-loaded pluronic P123/F127 mixed micelles against non-small cell lung cancer based on passive tumor targeting and modulation of drug resistance.
Zhang W; Shi Y; Chen Y; Yu S; Hao J; Luo J; Sha X; Fang X
Eur J Pharm Biopharm; 2010 Aug; 75(3):341-53. PubMed ID: 20451605
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional Pluronic P123/F127 mixed polymeric micelles loaded with paclitaxel for the treatment of multidrug resistant tumors.
Zhang W; Shi Y; Chen Y; Ye J; Sha X; Fang X
Biomaterials; 2011 Apr; 32(11):2894-906. PubMed ID: 21256584
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of inhibition of P-glycoprotein mediated efflux by Pluronic P123/F127 block copolymers: relationship between copolymer concentration and inhibitory activity.
Wei Z; Yuan S; Hao J; Fang X
Eur J Pharm Biopharm; 2013 Feb; 83(2):266-74. PubMed ID: 23089310
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: formulation, optimization and in vitro characterization.
Wei Z; Hao J; Yuan S; Li Y; Juan W; Sha X; Fang X
Int J Pharm; 2009 Jul; 376(1-2):176-85. PubMed ID: 19409463
[TBL] [Abstract][Full Text] [Related]
5. Pluronic-based functional polymeric mixed micelles for co-delivery of doxorubicin and paclitaxel to multidrug resistant tumor.
Chen Y; Zhang W; Huang Y; Gao F; Sha X; Fang X
Int J Pharm; 2015 Jul; 488(1-2):44-58. PubMed ID: 25899286
[TBL] [Abstract][Full Text] [Related]
6. [Preparation, characterization of paclitaxel-loaded Pluronic P105 polymeric micelles and in vitro reversal of multidrug resistant tumor].
Wang YZ; Fang XL; Li YJ; Zhang ZW; Han LM; Sha XY
Yao Xue Xue Bao; 2008 Jun; 43(6):640-6. PubMed ID: 18822969
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and biodistribution of polymeric micelles of paclitaxel with Pluronic P123.
Han LM; Guo J; Zhang LJ; Wang QS; Fang XL
Acta Pharmacol Sin; 2006 Jun; 27(6):747-53. PubMed ID: 16723095
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel delivered by CD44 receptor-targeting and endosomal pH sensitive dual functionalized hyaluronic acid micelles for multidrug resistance reversion.
Liu Y; Zhou C; Wei S; Yang T; Lan Y; Cao A; Yang J; Hou Y
Colloids Surf B Biointerfaces; 2018 Oct; 170():330-340. PubMed ID: 29936386
[TBL] [Abstract][Full Text] [Related]
9. Polymeric complex micelles with double drug-loading strategies for folate-mediated paclitaxel delivery.
Li M; Liu Y; Feng L; Liu F; Zhang L; Zhang N
Colloids Surf B Biointerfaces; 2015 Jul; 131():191-201. PubMed ID: 25988283
[TBL] [Abstract][Full Text] [Related]
10. The potential of Pluronic polymeric micelles encapsulated with paclitaxel for the treatment of melanoma using subcutaneous and pulmonary metastatic mice models.
Zhang W; Shi Y; Chen Y; Hao J; Sha X; Fang X
Biomaterials; 2011 Sep; 32(25):5934-44. PubMed ID: 21596432
[TBL] [Abstract][Full Text] [Related]
11. Redox-responsive F127-folate/F127-disulfide bond-d-α-tocopheryl polyethylene glycol 1000 succinate/P123 mixed micelles loaded with paclitaxel for the reversal of multidrug resistance in tumors.
Lin J; Zhao C; Liu C; Fu S; Han L; Lu X; Yang C
Int J Nanomedicine; 2018; 13():805-830. PubMed ID: 29445276
[TBL] [Abstract][Full Text] [Related]
12. Systemic delivery of micelles loading with paclitaxel using N-succinyl-palmitoyl-chitosan decorated with cRGDyK peptide to inhibit non-small-cell lung cancer.
Yuan ZQ; Li JZ; Liu Y; Chen WL; Yang SD; Zhang CG; Zhu WJ; Zhou XF; Liu C; Zhang XN
Int J Pharm; 2015 Aug; 492(1-2):141-51. PubMed ID: 26188316
[TBL] [Abstract][Full Text] [Related]
13. Pluronic P105/F127 mixed micelles for the delivery of docetaxel against Taxol-resistant non-small cell lung cancer: optimization and in vitro, in vivo evaluation.
Chen L; Sha X; Jiang X; Chen Y; Ren Q; Fang X
Int J Nanomedicine; 2013; 8():73-84. PubMed ID: 23319859
[TBL] [Abstract][Full Text] [Related]
14. Enhanced antiproliferative and apoptosis effect of paclitaxel-loaded polymeric micelles against non-small cell lung cancers.
Zhang XY; Zhang YD
Tumour Biol; 2015 Jul; 36(7):4949-59. PubMed ID: 25702089
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel-loaded N-octyl-O-sulfate chitosan micelles for superior cancer therapeutic efficacy and overcoming drug resistance.
Jin X; Mo R; Ding Y; Zheng W; Zhang C
Mol Pharm; 2014 Jan; 11(1):145-57. PubMed ID: 24261922
[TBL] [Abstract][Full Text] [Related]
16. Overcoming drug-resistant lung cancer by paclitaxel loaded tetrahedral DNA nanostructures.
Xie X; Shao X; Ma W; Zhao D; Shi S; Li Q; Lin Y
Nanoscale; 2018 Mar; 10(12):5457-5465. PubMed ID: 29484330
[TBL] [Abstract][Full Text] [Related]
17. Mixed micelles of PEG(2000)-DSPE and vitamin-E TPGS for concurrent delivery of paclitaxel and parthenolide: enhanced chemosenstization and antitumor efficacy against non-small cell lung cancer (NSCLC) cell lines.
Gill KK; Kaddoumi A; Nazzal S
Eur J Pharm Sci; 2012 May; 46(1-2):64-71. PubMed ID: 22369858
[TBL] [Abstract][Full Text] [Related]
18. Co-delivery of paclitaxel and survivin shRNA by pluronic P85-PEI/TPGS complex nanoparticles to overcome drug resistance in lung cancer.
Shen J; Yin Q; Chen L; Zhang Z; Li Y
Biomaterials; 2012 Nov; 33(33):8613-24. PubMed ID: 22910221
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel.
Zhang C; Qu G; Sun Y; Wu X; Yao Z; Guo Q; Ding Q; Yuan S; Shen Z; Ping Q; Zhou H
Biomaterials; 2008 Mar; 29(9):1233-41. PubMed ID: 18093646
[TBL] [Abstract][Full Text] [Related]
20. Poly(caprolactone)-modified Pluronic P105 micelles for reversal of paclitaxcel-resistance in SKOV-3 tumors.
Wang Y; Hao J; Li Y; Zhang Z; Sha X; Han L; Fang X
Biomaterials; 2012 Jun; 33(18):4741-51. PubMed ID: 22445254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
